Evidence map›Paper›PMID 35095541›Full record

ArticleFrontiers in physiology2021

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic

William J Valentine, Sherif A Mostafa, Suzumi M Tokuoka, Fumie Hamano, Natsuko F Inagaki, Joel Z Nordin, Norio Motohashi, Yoshihiro Kita, Yoshitsugu Aoki, Takao Shimizu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A fat- and sucrose-enriched diet causes metabolic alterations in mdx mice.American journal of physiology. Regulatory, integrative and comparative physiology · 2023
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

William J ValentineDepartment of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Kodaira, Tokyo, Japan.
Sherif A MostafaDepartment of Lipid Signaling, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.
Suzumi M TokuokaDepartment of Lipidomics, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
Fumie HamanoDepartment of Lipid Signaling, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.
Natsuko F InagakiDepartment of Lipid Signaling, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.
Joel Z NordinDepartment of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Kodaira, Tokyo, Japan.
Norio MotohashiDepartment of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Kodaira, Tokyo, Japan.
Yoshihiro KitaLife Sciences Core Facility, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
Yoshitsugu AokiDepartment of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Kodaira, Tokyo, Japan.
Takao ShimizuDepartment of Lipid Signaling, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.
Hideo ShindouDepartment of Lipid Signaling, National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Japan.
National Center for Global Health and Medicine · JPNational Center of Neurology and Psychiatry · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Duchenne muscular dystrophy (DMD), lack of dystrophin increases the permeability of myofiber plasma membranes to ions and larger macromolecules, disrupting calcium signaling and leading to progressive muscle wasting. Although the biological origin and meaning are unclear, alterations of phosphatidylcholine (PC) are reported in affected skeletal muscles of patients with DMD that may include higher levels of fatty acid (FA) 18:1 chains and lower levels of FA 18:2 chains, possibly reflected in relatively high levels of PC 34:1 (with 16:0_18:1 chain sets) and low levels of PC 34:2 (with 16:0_18:2 chain sets). Similar PC alterations have been reported to occur in the

Indexed as

Duchennemdxmuscular dystrophyoleic acidphosphatidylcholinephospholipidskeletal muscle

Identifiers

PMID35095541
PMCPMC8791236
OpenAlexW4206265569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.